HIV-Associated Neurocognitive Disorder After the Start of Combination Antiretroviral Therapy.

The article offers information on HIV-associated neurocognitive disorder after administering combination antiretroviral therapy (cART). Topics discussed include natural history of HIV-associated neurocognitive disorders (HAND), evolving brain pathology in HAND, and pathophysiology of HAND in the pre...

Full description

Bibliographic Details
Published in:	Psychiatric Times Vol. 36; no. 9; pp. 46 - 51
Main Authors:	González-Scarano, Francisco, Kolson, Dennis L.
Format:	Article
Published:	MJH Life Sciences Sep2019
Subjects:	Cognition disorders diagnosis Cognition disorder risk factors Dementia risk factors Diagnosis of HIV infections HIV infections & psychology HIV infection complications Blood-brain barrier Brain Central nervous system Combination drug therapy HIV infections Lymphocytes Macrophages Magnetic resonance imaging Neuropsychological tests Antiretroviral agents Continuing education units Disease prevalence Severity of illness index
Online Access:	View this record in EBSCOhost

Description
Summary:	The article offers information on HIV-associated neurocognitive disorder after administering combination antiretroviral therapy (cART). Topics discussed include natural history of HIV-associated neurocognitive disorders (HAND), evolving brain pathology in HAND, and pathophysiology of HAND in the pre- and post-cART eras.